Tandem Diabetes Care, Inc. (TNDM) News
Filter TNDM News Items
TNDM News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
TNDM News Highlights
- TNDM's 30 day story count now stands at 4.
- Over the past 20 days, the trend for TNDM's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- SIGI, PRE and SA are the most mentioned tickers in articles about TNDM.
Latest TNDM News From Around the Web
Below are the latest news stories about TANDEM DIABETES CARE INC that investors may wish to consider to help them evaluate TNDM as an investment opportunity.
Tandem Diabetes Care Completes Acquisition of Insulin Patch Pump Developer, AMF MedicalSAN DIEGO, January 23, 2023--Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, today announced the completion of its previously announced acquisition of AMF Medical SA, the privately held Swiss developer of the Sigi™ Patch Pump. The Sigi Patch Pump, designed to be an ergonomic, rechargeable patch pump that reduces the burden of managing diabetes through its use of pre-filled insulin cartridges, is under development and not commercially available |
Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2022 Financial Results on February 22, 2023SAN DIEGO, January 19, 2023--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2022 results after the financial markets close on Wednesday, February 22, 2023. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its fourth quarter and full year 2022 financial and operating results. |
Tandem Diabetes Care Reports Preliminary, Unaudited 2022 Sales and Reaffirms 2023 OutlookSAN DIEGO, January 10, 2023--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, today reported its preliminary, unaudited sales for the fourth quarter and year ended December 31, 2022 and worldwide sales outlook for the year ending December 31, 2023. |
Tandem Diabetes Care to Present at the 41st Annual J.P. Morgan Healthcare ConferenceSAN DIEGO, January 03, 2023--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023 at 8:15pm Eastern Time (5:15pm Pacific Time). |
2 Stocks Down 72% or More to Buy in 2023 and Hold for 10 YearsFor those who need inspiration, let's consider two stocks that have been trashed this year but still boast solid, long-term prospects: Tandem Diabetes Care (NASDAQ: TNDM) and Roku (NASDAQ: ROKU). In the next decade, Tandem Diabetes Care can count on its disruptive innovations and the increase in the number of diabetes patients to deliver outsize returns. The company's t:slim X2 insulin pump is much easier on people with diabetes than multiple daily injections (MDIs) and Tandem's product provides features that most don't offer, including continuous glucose monitoring integration to automate the insulin delivery system completely. |
Tandem Diabetes Acquires Swiss Based Insulin Patch Pump DeveloperTandem Diabetes Care Inc (NASDAQ: TNDM) has agreed to acquire AMF Medical SA, the privately held Swiss developer of the investigational Sigi Patch Pump. It is designed to be an ergonomic, rechargeable patch pump that reduces the burden of managing diabetes through its use of pre-filled insulin cartridges and its compatibility with automated insulin delivery technology. The acquisition expands Tandem's type 1 and type 2 addressable market opportunities. Tandem Diabetes Care will acquire AMF Medic |
Tandem Diabetes Care (TNDM) Stock Declined in Q3 Due to CompetitionChartwell Investment Partners, an affiliate of Carillon Tower Advisers, an investment management company, released its “Carillon Chartwell Small Cap Growth Fund” third quarter 2022 investor letter. A copy of the same can be downloaded here. The fund slightly underperformed relative to its benchmark Russell 2000 Growth Index. The letter noted that although there is a positive momentum […] |
Tandem Diabetes to acquire Swiss insulin pump maker AMF MedicalTandem Diabetes Care Inc. , an insulin delivery and diabetes technology company, said Tuesday it has entered a definitive agreement to acquire AMF Medical SA, a Swiss privately held maker of the Sigi Patch Pump. The pump is currently under development and is not commercially available. "It is designed to be an ergonomic, rechargeable patch pump that reduces the burden of managing diabetes through its use of pre-filled insulin cartridges and its compatibility with automated insulin delivery techn |
Tandem Diabetes Care to Acquire Insulin Patch Pump Developer, AMF MedicalSAN DIEGO, December 13, 2022--Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, today announced that it has entered into a definitive agreement to acquire AMF Medical SA, the privately held Swiss developer of the Sigi™ Patch Pump. The Sigi Patch Pump is under development and not commercially available. It is designed to be an ergonomic, rechargeable patch pump that reduces the burden of managing diabetes through its use of pre-filled insulin car |
11 Best Diabetes Stocks To Buy NowIn this article, we discuss 11 best diabetes stocks to buy now. If you want to see more stocks in this selection, check out 5 Best Diabetes Stocks To Buy Now. The global diabetes market is segmented based on the type, drug class, and devices used to treat the condition. Based on the type, the […] |